Timentin

Company
SmithKline Beecham

Approval Status
Approved January 1998

Treatment for
Infections in children

Possible similar drugs
Timentin

Areas
Immune System , Pediatrics

Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of infections in children aged 3 months to 16 years. The drug was previously approved for use in adult patients.

Timentin Drug Information

The Timentin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top